Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
High Blood Pressure & Cardiovascular Prevention
Published in: High Blood Pressure & Cardiovascular Prevention 3/2008

01-07-2008 | Contributions from International Congress

5.17 Effects of Chronic Angiotensin II Administration on MicroRNA Expression in Rat Cardiovascular System

Authors: G. Castoldi, C. di Gioia, C. Bombardi, M. Mancini, M. Leopizzi, B. Corradi, G. Zerbini, A. Stella

Published in: High Blood Pressure & Cardiovascular Prevention | Issue 3/2008

Login to get access

Excerpt

Introduction. Angiotensin II (Ang II) promotes hypertrophy/hyperplasia, inflammation, and fibrosis in the cardiovascular system through a complex regulation of gene expression/protein translation. MicroRNA are key regulators of gene expression and miR-1,miR-21, miR-133a, and miR-208 are involved in cardiovascular pathology. …
Metadata
Title
5.17 Effects of Chronic Angiotensin II Administration on MicroRNA Expression in Rat Cardiovascular System
Authors
G. Castoldi
C. di Gioia
C. Bombardi
M. Mancini
M. Leopizzi
B. Corradi
G. Zerbini
A. Stella
Publication date
01-07-2008
Publisher
Springer International Publishing
Published in
High Blood Pressure & Cardiovascular Prevention / Issue 3/2008
Print ISSN: 1120-9879
Electronic ISSN: 1179-1985
DOI
https://doi.org/10.1007/BF03263637

Other articles of this Issue 3/2008

High Blood Pressure & Cardiovascular Prevention 3/2008 Go to the issue

Contributions from International Congress

9.11 Association between Plasma Aldosterone, Metabolic Syndrome and Left Ventricular Mass in Essential Hypertension

Contributions from International Congress

4.5 Linkage of Familial Hyperaldosteronism Type II at Chromosome 7p22 in Two Italian Families

Contributions from International Congress

1.2 Comparison Between CRP and Other Conventional Risk Factors on Arterial Stiffness in Treated Essential Hypertension

Contributions from International Congress

9.16 Hypertension Leads to Type 2 Diabetes Mellitus

Contributions from International Congress

1.8 A Functional LDL Receptor-Related Protein 6 Gene Variant is an Independent Risk Factor For Early Carotid Artery Atherosclerosis in Hypertensive Patients

Contributions from International Congress

11.3 Ambulatory Monitoring of Blood Pressure (AMBP) in Young People with Obstructive Sleep Apnoea Syndrome (OSAS